GlassScriptPhysician profile
Anibal J Lugo
NPI 1245307545
$4,329.38
in general payments reported to CMS, 2019-2025
15 companies · $798 in 2025
The $798 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $322 · 2021: $436 · 2022: $754 · 2023: $912 · 2024: $561 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,271.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,656.42 | 2019-2025 | Onyx Frontier, Telescope, Euphora |
| Abbott Laboratories | $540.53 | 2022-2025 | Aveir, Xience Sierra, Xience Skypoint |
| Boston Scientific Corporation | $408.61 | 2019-2025 | Comet, Ffr Link Bluetooth Communication Module, Opticross |
| Astrazeneca Pharmaceuticals LP | $346.69 | 2019-2025 | Lokelma, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $338.27 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.28 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $228.14 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $210.69 | 2019-2020 | |
| Chiesi USA, INC. | $98.24 | 2021-2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $89.33 | 2024 | Camzyos |
| Terumo Medical Corporation | $42.92 | 2019-2025 | Heartrail |
| Cordis US Corp. | $39.10 | 2021-2025 | Rain Sheath |
| Edwards Lifesciences Corporation | $29.09 | 2021 | |
| Pbg Puerto Rico LLC | $25.65 | 2025 | |
| Sk Life Science, INC. | $12.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anibal Lugo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.